The two tumors expressing the greatest number of fusion genes were ETS negative (tumor T4 and LTL311; also SPOP wild type), consistent with Baca et al.’s work demonstrating a higher frequency of genome rearrangement in this tumor subtype compared to ETS positive tumors [6]. The gene discussed is SPOP; the disease is neoplasm.